期刊文献+

术中植入缓释型氟尿嘧啶治疗进展期胃癌的安全性 被引量:2

原文传递
导出
摘要 目的 探讨手术中植入缓释型氟尿嘧啶治疗进展期胃癌患者的安全性.方法 将109例胃癌患者随机分成3组,分别给予术中植入400mg或800mg缓释型氟尿嘧啶以及单纯手术,检测各组术前、术后的肝肾功能、红细胞、白细胞以及免疫学指标CD3、CD4和CD8的变化.结果 治疗组和对照组比较,各项检测指标无论在术前还是术后均差异无统计学意义(P〉0.05).结论 术中植入缓释型氟尿嘧啶治疗胃癌是安全的.
作者 马剑方
出处 《肿瘤研究与临床》 CAS 2010年第5期349-351,共3页 Cancer Research and Clinic
  • 相关文献

参考文献10

  • 1Marutsuka T,Shimada S,Shiomori K,et al.Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma:an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis.Clin Cancer Res,2003,9:678-685.
  • 2Yoo CH,Noh SH,Shin DW,et al.Recurrence following curative resection for gastric carcinoma.Br J Surg,2000,87:236-242.
  • 3Hermans J,Bonenkamp JJ,Boon MC,et al.Adjuvant therapy after curative resection for gastric cancer:meta-analysis of randomized trials.J Clin Oncol,1993,11:1441-1447.
  • 4Janunger KG,Hafstrom L,Nygren P,et al. systematic overview of chemotherapy effects in gastric cancer.Acta Oncol,2001,40:309-326.
  • 5Kaibara N,Hamazoe R,Iitsuka Y,et al.Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer.Hepatogastroenterology,1989,36:75-78.
  • 6Longley DB,Harkin D P,Johnston PG.5-fluorouracil:mechanisms of action and clinical strategies.Nat Rev Cancer,2003,3:330-338.
  • 7Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res, 1983, 43: 1488-1492.
  • 8姜福全,王强,蔡清萍,杨伟志.5-氟尿嘧啶腹腔内缓释化疗对H22腹水瘤小鼠的抑瘤疗效观察[J].第二军医大学学报,2006,27(11):1207-1209. 被引量:4
  • 9Lennard TW,Shenton BK,Borzotta A,et al.The influence of surgical operations on components of the human immune system.Br J Surg,1985,72:771-776.
  • 10饶芸,雷玉洁,雷晓,宋娟,余佩武,蔡志民.胃癌术后化疗对外周血免疫细胞比例及凋亡的影响[J].重庆医学,2004,33(9):1331-1332. 被引量:3

二级参考文献13

共引文献5

同被引文献49

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部